Abstract:Background: Extramammary Paget's disease (EMPD) is a rare cutaneous malignant tumor with a high recurrence rate after surgery. However, the genetic and epigenetic alterations underlying its pathogenesis remain unknown. DNA methylation is an important epigenetic modification involved in many biological processes. Methods: In this study, enzymatic methyl-sequencing (EM-seq) technique was used to investigate the landscape of genome-wide DNA methylation from three pairs of tumor tissues and adjacent tissues of patients with EMPD. Additionally, we conducted histopathological examinations to assess the expression of fatty acid-binding protein 5 (FABP5) in another three paired samples from EMPD patients. Results: The cluster analysis showed the good quality of the samples. A differential methylation region (DMR) heat map was used to quantitatively characterize genome-wide methylation differences between tumors and controls. Global DNA methylation level is lower in EMPD tissue compared to matched controls, indicating that DNA methylation discriminates between tumor and normal skin. And the top hypomethylation gene on the promoter region in tumor tissues was FABP5 on chromosome 8 with 38.44% decreased median methylation. We next identified the expression of FABP5 in paired tumors and adjacent tissues in three additional patients with EMPD. Immunofluorescence results showed FABP5 highly expressed in tumor tissues and co-located with CK7, CK20 and EMA. GO and KEGG enrichment analysis showed DMR genes on promoter are mainly enriched in the calcium ion transport, GTPase mediated signal transduction, Rap1 signaling pathway and GnRH signaling pathway. Conclusion: Taken together, our findings provide the first description of the whole genome methylation map of EMPD and identify FABP5 as a pathogenic target of EMPD.

Pi3k, Rac1 And Ppak1 Are Overexpressed In Extramammary Paget'S Disease

Oncogenic Mutations In Extramammary Paget'S Disease And Their Clinical Relevance

Clinical Features and Follow Up Analysis of 19 Patients Wit Extramammary Paget Disease

Expression of p38 MAPK/NF-κB/cyclin D1 Signaling Pathway in Extramammary Paget's Disease

Microarray-based Identification of Differentially Expressed Genes in Extramammary Paget's Disease.

The expression of β- catenin and cyclinD1 in extramammary Paget's disease

Immunotherapy May Be More Appropriate for ERBB2 Low-Expressing Extramammary Paget’s Disease Patients: a Prognosis Analysis and Exploration of Targeted Therapy and Immunotherapy of Extramammary Paget’s Disease Patients

133 Distinctive Mirna Expression Profiles in Tissue and Serum of Primary Extramammary Pagets Disease

Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A

Expression and Its Biological Significance of Osteopontin(OPN)and CD44v6 in Extramammary Paget's Disease

Expression of Survivin and Human Telomerase Reverse Transcriptase in Extramammary Paget's Disease

Expression and Prognostic Significance of Stat5a and E‐cadherin in Extramammary Paget’s Disease

Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget Disease.

Implication of Pin1 Expression in Extramammary Paget's Disease

Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease

Distribution of Cytokeratin5/6(CK5/6) and Cytokeratin14 (CK14) in Extramammary Paget's Disease

The Detection and Correlation Analysis of P16 and PCNA in Extramammary Paget′s Disease

Clinical and Pathological Characteristics of Extramammary Paget's Disease: Report of 246 Chinese Male Patients.

Ultrasound Biomicroscopy and High-Frequency Ultrasound for Evaluating Extramammary Paget Disease with Pathologic Correlation

Genetic Analysis of Mismatch Repair Genes Alterations in Extramammary Paget Disease.

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance